Reply to Editorial Comment on “Clinician- and Geographic-level Variation in Utilization of Sacral Neuromodulation and OnabotulinumtoxinA Injections Among Medicare Beneficiaries With Overactive Bladder”

Posted by author-avatar

Publication date: Available online 18 December 2025

Source: Urology

Author(s): Leo D. Dreyfuss, Anne M. Suskind

Read More

Newer
Editorial Comment on “Unraveling Smooth Muscle-Rich Renal Cell Carcinoma: Clinical, Oncological, Genetic, and Pathological Insights”
Older Sociodemographic Factors Associated With Tissue-based Genomic Testing for Prostate Cancer